Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

699 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

NCT07060807

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Southern Cancer Center (SCC) ( Site 8000) Daphne, Alabama, United States
  • The University of Arizona Cancer Center - North Campus ( Site 0055) Tucson, Arizona, United States
  • Los Angeles Hematology Oncology Medical Group ( Site 0026) Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian ( Site 0025) Newport Beach, California, United States
View all 199 locations
View Trial Details
Recruiting

Biennial CEM in Women With a Personal History of Breast Cancer

NCT06105749

Conditions
Breast Cancer, Breast Cancer Female, Breast Diseases, +5 more
Locations
  • UPMC Magee-Womens Imaging - Bethel Park Bethel Park, Pennsylvania, United States
  • UPMC Magee at the Lemieux Sports Complex Cranberry Township, Pennsylvania, United States
  • Magee Womancare Monroeville Monroeville, Pennsylvania, United States
  • Magee-Womens Hospital Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

NCT06926868

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Local Institution - 0303 Hot Springs, Arkansas, United States
  • Helios Clinical Research Cerritos, California, United States
  • Local Institution - 0307 Cerritos, California, United States
  • Local Institution - 0308 Cerritos, California, United States
View all 295 locations
View Trial Details
Recruiting

A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence

NCT06830720

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Novartis Investigative Site Wiener Neustadt, Lower Austria, Austria
  • Novartis Investigative Site Innsbruck, Tyrol, Austria
  • Novartis Investigative Site Linz, Upper Austria, Austria
  • Novartis Investigative Site Graz, Austria
View all 287 locations
View Trial Details

Related conditions